Bioequivalence of Saxagliptin/Metformin Extended-Release (XR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin XR Tablets in Healthy Adult Subjects

被引：0
作者：
David W. Boulton
Charles H. Smith
L. Li
Jian Huang
Angela Tang
Frank P. LaCreta
机构：
[1] Bristol-Myers Squibb,
[2] PPD,undefined
来源：
Clinical Drug Investigation | 2011年 / 31卷
关键词：
Metformin; Saxagliptin; Tablet Core; Healthy Adult Subject; Initial Combination Therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background and Objectives: As compared with individual tablets, saxagliptin/metformin extended-release (XR) fixed-dose combination (FDC) tablets offer potential for increased patient compliance with the convenience of once-daily dosing. Two bioequivalence studies assessed the fed-state bioequivalence of saxagliptin/metformin XR 5 mg/500 mg FDC (study 1) and saxagliptin/metformin XR 5mg/1000 mg FDC (study 2) relative to the same dosage strengths of individual component tablets administered concurrently. The effect of food on saxagliptin and metformin pharmacokinetics from the saxagliptin/metformin XR 5 mg/500 mg FDC and their steady-state pharmacokinetics from the saxagliptin/metformin XR 5 mg/1000 mg were also investigated.
引用
收藏
页码：619 / 630
页数：11
相关论文
共 50 条
[41]   Bioequivalence Evaluation in Healthy Volunteers: New Generic Formulations of Sitagliptin and Sitagliptin–Metformin Fixed-Dose Combination Compared with the Originator Products [J].
Yvonne Schnaars ;
Sumedh Gaikwad ;
Ulrike Gottwald-Hostalek ;
Wolfgang Uhl ;
Olga Ribot ;
Kanthikiran V. S. Varanasi ;
Laura Rodríguez ;
Javier Torrejón ;
Luis Gómez .
Diabetes Therapy, 2023, 14 :347-362
[42]   Bioequivalence Evaluation in Healthy Volunteers: New Generic Formulations of Sitagliptin and Sitagliptin-Metformin Fixed-Dose Combination Compared with the Originator Products [J].
Schnaars, Yvonne ;
Gaikwad, Sumedh ;
Gottwald-Hostalek, Ulrike ;
Uhl, Wolfgang ;
Ribot, Olga ;
Varanasi, Kanthikiran V. S. ;
Rodriguez, Laura ;
Torrejon, Javier ;
Gomez, Luis .
DIABETES THERAPY, 2023, 14 (02) :347-362
[43]   An open-label, multiple-dose study to assess the pharmacokinetics and tolerability of a sitagliptin/metformin fixed-dose combination (FDC) tablet in healthy Chinese adult subjects [J].
Chen, Xia ;
Zhao, Qian ;
Zhang, Jianyan ;
Liu, Tao ;
Jiang, Ji ;
Hu, Pei .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2016, 54 (09) :705-711
[44]   Comparison of the Bioavailability and Tolerability of Fixed-Dose Combination Glimepiride/Metformin 2/500-mg Tablets Versus Separate Tablets: A Single-Dose, Randomized-Sequence, Open-Label, Two-Period Crossover Study in Healthy Korean Volunteers [J].
Gu, Namyi ;
Kim, Bo-Hyung ;
Rhim, HyouYoung ;
Chung, Jae-Yong ;
Kim, Jung-Ryul ;
Shin, Hyun-Suk ;
Yoon, Seo-Hyun ;
Cho, Joo-Youn ;
Shin, Sang-Goo ;
Jang, In-Jin ;
Yu, Kyung-Sang .
CLINICAL THERAPEUTICS, 2010, 32 (07) :1408-1418
[45]   Effects of food on the pharmacokinetics of a gemigliptin/metformin sustained-release 50/1,000 mg (25/500 mg x 2 tablets) fixed-dose combination tablet in healthy male volunteers [J].
Choi, Hee Youn ;
Noh, Yook-Hwan ;
Kim, Yo Han ;
Kim, Mi Jo ;
Lee, Shi Hyang ;
Kim, Jeong-Ae ;
Kim, Bogyeong ;
Lim, Hyeong-Seok ;
Bae, Kyun-Seop .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2014, 52 (05) :381-391
[46]   Pharmacokinetics and Bioequivalence of Two Combination Metformin/Glipizide Tablets under Fasting and Fed Conditions in Chinese Healthy Subjects: A Randomized, Open-Label, Crossover Study [J].
Lei, Yuyan ;
Yan, Yu ;
Huang, Lifeng ;
Li, Canxia ;
Liu, Wanying ;
Shen, Qiuxia ;
Wang, Caihong ;
Yang, Hongying ;
Li, Xiaohui ;
Zhang, Wanyu ;
Chen, Jing ;
Su, Jiankun ;
Xie, Yuhong ;
Chen, Weiming ;
Li, Chao ;
Lu, Junli ;
Chen, Lulu .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2024, 2024
[47]   Bioequivalence of China- and Germany-Manufactured Metformin Extended-Release Tablets Under Fed and Fasted Conditions in Healthy Volunteers: A Randomized, Open-Label, 2-Way Crossover Study [J].
Hu, Chaoying ;
Pei, Tong ;
Li, Dandan ;
Zhou, Dongli ;
Zhang, Lan .
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (12) :1430-1439
[48]   Oral antidiabetic drugs: Bioavailability assessment of fixed-dose combination tablets of pioglitazone and metformin. Effect of body weight, gender, and race on systemic exposures of each drug [J].
Karim, Aziz ;
Slater, Margaret ;
Bradford, Dawn ;
Schwartz, Lisa ;
Zhao, Zhen ;
Cao, Charlie ;
Laurent, Aziz .
JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (01) :37-47
[49]   Effect of food on the pharmacokinetics of canagliflozin/metformin (150/1,000 mg) immediate-release fixed-dose combination tablet in healthy participants [J].
Murphy, Joseph ;
Wang, Shean-Sheng ;
Stieltjes, Hans ;
Wajs, Ewa ;
Devineni, Damayanthi .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2015, 53 (03) :256-264
[50]   Pharmacokinetics of a Fixed-Dose Combination of Atorvastatin and Metformin Extended Release versus Concurrent Administration of Individual FormulationsA Randomized, Open-Label, Two-Treatment, Two-Period, Two-Sequence, Single-Dose, Crossover, Bioequivalence Study [J].
Kirti Kandhwal ;
Surajit Dey ;
Shabana Nazarudheen ;
Rachna Arora ;
Simrit Reyar ;
Nageshwar R. Thudi ;
Tausif Monif ;
Manoj K. Singh ;
Shireen Rao .
Clinical Drug Investigation, 2011, 31 :853-863
12345